ArticleBlood advances2025

NKTR-255 enhances complete response following CD19 CAR T-cell therapy in patients with relapsed/refractory large B-cell lymphoma.

Sairah Ahmed et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.